Better medicine against glioblastoma cancer

17 December 2018

Article in SciLifeLab Synergy 2, 2018

Beactica's Head of Discovery, Dr Ulf Bremberg, explains how the company’s specialist small molecule drug discovery platform is developing a novel therapy for glioblastoma. 

Read full article here.

See all recent coverage

Stay Updated

Sign up for the Beactica newsletter to receive our latest news and updates

This website uses cookies to improve your user experience. By continuing to browse this site, you agree to our use of cookies. More information. Ok!